Edmond de Rothschild Asset Management (France)’s Vertex Pharmaceuticals VRTX Stock Holding History

Edmond de Rothschild Asset Management (France)’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$16.6M	Sell	190,000 -10,000	-5%	-$945K	0.72%	43
2016 Q2	$17.2M	Buy	200,000 +11,700	+6%	+$1.01M	0.77%	40
2016 Q1	$15M	Buy	188,300 +58,300	+45%	+$5.27M	0.65%	48
2015 Q4	$16.4M	Buy	130,000 +15,000	+13%	+$1.81M	0.58%	54
2015 Q3	$12M	Buy	+115,000	New	+$14.8M	0.4%	67

Other funds holding VRTX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Edmond de Rothschild Asset Management (France)'s VRTX Position: Q3 2016 in Review

Edmond de Rothschild Asset Management (France) reduced its Vertex Pharmaceuticals (VRTX) stake by 5% in Q3 2016, selling an estimated $945K and leaving 190,000 shares worth $16.6M. The position accounts for 0.72% of the portfolio, ranked #43.

Edmond de Rothschild Asset Management (France) first reported a position in VRTX in Q3 2015 and has held it in 5 quarters since. The position peaked at $17.2M in Q2 2016. 490 funds tracked by Wall St. Rank hold VRTX as of Q3 2016.

Edmond de Rothschild Asset Management (France) held 190,000 shares of Vertex Pharmaceuticals worth $16.6M as of Q3 2016.
Edmond de Rothschild Asset Management (France) sold 10,000 Vertex Pharmaceuticals shares in Q3 2016, an estimated $945K.
Vertex Pharmaceuticals made up 0.72% of Edmond de Rothschild Asset Management (France)'s portfolio in Q3 2016, its #43 holding.
Edmond de Rothschild Asset Management (France) first reported a position in Vertex Pharmaceuticals in Q3 2015 and has held it in 5 quarters since.
Edmond de Rothschild Asset Management (France)'s Vertex Pharmaceuticals position peaked at $17.2M in Q2 2016.
490 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2016.

Based on Edmond de Rothschild Asset Management (France)'s 13F filing for Q3 2016, filed 14 Nov 2016.